Govt Welcomes Production of Insulin in South Africa

"The collaboration between Novo Nordisk, a global leader in diabetic research and innovation, and Aspen, Africa's largest pharmaceutical manufacturer, will facilitate the production of human insulin," Minister of Trade, Industry and Competition, Ebrahim Patel said.

The production of insulin will use Aspen's sterile infrastructure in the city of Gqeberha in South Africa, including some of the infrastructure that was used for Covid-19 vaccine manufacture. Aspen will deploy 250 people for this production, which will start in early 2024, and will reduce the transport-related carbon footprint by 68%.

InFocus

Insulin syringe (file photo).

Follow AllAfrica

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.